Controversies in the Treatment of Women with ST-Segment Elevation Myocardial Infarction

Area of Science:

• Cardiology
• Women's Health
• Cardiovascular Disease

Background:

• Coronary artery disease (CAD) is the primary cause of mortality in women globally.
• Women experiencing ST-segment elevation myocardial infarctions (STEMI) exhibit poorer prognoses compared to men, even with advanced treatments.
• Outcome disparities are especially evident in younger men and women diagnosed with myocardial infarctions.

Purpose of the Study:

• To review current treatment modalities for ST-segment elevation myocardial infarctions (STEMI).
• To analyze the outcomes of women undergoing reperfusion therapy for STEMI.
• To highlight the benefits of aggressive treatment strategies for women with STEMI.

Main Methods:

• Literature review of studies on STEMI treatment and outcomes in women.
• Analysis of data comparing outcomes between men and women with STEMI.
• Examination of the impact of reperfusion therapies on female STEMI patients.

Main Results:

• Women with STEMI have worse outcomes than men, a gap that is pronounced in younger populations.
• Differences in plaque development, disease presentation, and recognition contribute to these disparities.
• Women demonstrate significant benefit from aggressive treatment and contemporary therapies for STEMI.

Conclusions:

• Despite facing worse outcomes, women derive substantial advantages from aggressive and up-to-date STEMI treatments.
• Understanding and addressing the unique pathophysiology and presentation in women is crucial for improving STEMI care.
• Reperfusion therapies, when applied aggressively, offer significant benefits to women recovering from STEMI.